ストックスクリーナーアプリを入手
53.23
1.31%
-0.6022
前日終値:
$53.83
開ける：
$53.75
24時間の取引高:
1.14M
Relative Volume:
0.87
時価総額：
$6.95B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-11.57
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
+14.02%
1か月 パフォーマンス:
+11.11%
6か月 パフォーマンス:
+45.70%
1年 パフォーマンス:
-40.96%
1日の値動き範囲:
$53.06
$56.04
1週間の範囲:
$44.85
$56.04
52週間の値動き範囲:
$27.66
$93.77
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
53.06 | 7.05B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.56 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.00 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.87 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.26 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 繰り返されました | Needham | Buy |
| 2025-09-12 | 開始されました | Goldman | Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Vaxcyte (PCVX) Advances VAX-31 Vaccine Trials - GuruFocus
Vaxcyte advances adult and infant programs for Vax-31, a potential best-in-class, next-generation pneumococcal conjugate vaccine - marketscreener.com
Vaxcyte Advances Adult and Infant Programs for VAX-31, a - GlobeNewswire
Campbell & CO Investment Adviser LLC Cuts Stake in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vaxcyte (NASDAQ:PCVX) Trading 7.4% HigherWhat's Next? - MarketBeat
Aug Update: Can Vaxcyte Inc stock hit record highs againCPI Data & Technical Entry and Exit Alerts - Bộ Nội Vụ
(PCVX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aug Patterns: Why Vaxcyte Inc. (5VA) stock remains stableTrade Analysis Summary & Proven Capital Preservation Methods - Bộ Nội Vụ
Vaxcyte, Inc. (PCVX) Stock Analysis: A Look At Its 121.74% Potential Upside - DirectorsTalk Interviews
Analyst Calls: Will Vaxcyte Inc. (5VA) stock test record highs in 2025Weekly Stock Analysis & Real-Time Market Sentiment Reports - Bộ Nội Vụ
CEO Change: Why Vaxcyte Inc stock could benefit from AI revolutionQuarterly Trade Summary & Expert Approved Momentum Ideas - moha.gov.vn
How Vaxcyte Inc. stock performs after earningsRecovery Day Options & choose cushioning that matches your runs - Улправда
Why Vaxcyte Inc. (5VA) stock could rally stronglyLong Run Comfort Guide & updated model highlights and notes - Улправда
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
How Vaxcyte Inc. (5VA) stock responds to bond market2025 Key Lessons & High Conviction Trade Alerts - Улправда
Why Vaxcyte Inc. stock could benefit from AI revolutionJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - Улправда
Why Vaxcyte Inc. stock attracts high net worth investorsJuly 2025 Weekly Recap & Expert Verified Stock Movement Alerts - Улправда
Is Vaxcyte Inc. (5VA) stock positioned for digital growth eraJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Will Vaxcyte Inc. (5VA) stock test record highs in 20252025 Trade Ideas & Long-Term Growth Plans - Улправда
Why Vaxcyte Inc. (5VA) stock remains stableMoving Average Strategies & Secret Picks Wall Street Isn’t Talking About - ulpravda.ru
Vaxcyte (PCVX) Gains Positive Outlook with Price Target Boost - GuruFocus
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes - Investing.com Canada
Stock Report: Is Vaxcyte Inc stock trading near support levelsSell Signal & Daily Profit Maximizing Trade Tips - moha.gov.vn
Vaxcyte (PCVX) Gains Favor After Immunization Schedule Update - GuruFocus
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator With Nearly 100% Upside Potential - DirectorsTalk Interviews
Vaxcyte Earnings Notes - Trefis
Vaxcyte's Chief Technical Ops Officer Sells Shares - AOL.com
Insider Sell Alert: Harpreet Dhaliwal Sells 9,743 Shares of Vaxc - GuruFocus
Harpreet Dhaliwal Sells 9,743 Shares of Vaxcyte (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price-Driven Insight from (PCVX) for Rule-Based Strategy - Stock Traders Daily
Vaxcyte shows rising price performance with jump to 81 RS rating - MSN
Trade Alert: Senior Vice President of Finance Of Vaxcyte Elvia Cowan Has Sold Stock - simplywall.st
Vaxcyte (NASDAQ:PCVX) Stock Price Up 3.9%Here's Why - MarketBeat
Insider Selling: Vaxcyte (NASDAQ:PCVX) SVP Sells 11,623 Shares of Stock - MarketBeat
Vaxcyte president and CFO sells shares worth $692,100 - MSN
Vaxcyte, Inc. $PCVX Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%. - Barron's
What Makes Vaxcyte (PCVX) So Attractive - Finviz
What makes Vaxcyte (PCVX) so attractive - MSN
How (PCVX) Movements Inform Risk Allocation Models - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Why Vaxcyte Inc. stock remains resilientJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - Улправда
Assenagon Asset Management S.A. Buys 171,974 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Will Vaxcyte Inc. stock keep outperforming rivalsM&A Rumor & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
How Vaxcyte Inc. stock performs during Fed tightening cyclesDay Trade & Safe Capital Allocation Plans - Улправда
How Vaxcyte Inc. stock performs in rate cut cyclesAnalyst Downgrade & Safe Capital Growth Trade Ideas - Улправда
Vaxcyte Enhances Executive Severance to Align With Market - TipRanks
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):